Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACUSPHERE INC | 152,944 | reported | 02 Jan 2009 | tx 6+242,444 |
| COLLEGIUM PHARMACEUTICAL, INC | 71,000 | reported | 14 May 2026 | tx 20+159,253−75,370 |
| Sirtris Pharmaceuticals, Inc. | 55,000 | reported | 02 Jan 2008 | tx 4+220,000 |
| Karyopharm Therapeutics Inc. | 18,517 | reported | 21 May 2026 | tx 15+321,448 |
| TETRAPHASE PHARMACEUTICALS INC | 16,500 | reported | 10 Jun 2019 | tx 7+91,500 |
| Protara Therapeutics, Inc. | 12,700 | reported | 08 Jun 2018 | tx 7+86,010 |
| Targanta Therapeutics Corp. | 10,000 | reported | 02 Jun 2008 | tx 1+10,000 |
| PRAECIS PHARMACEUTICALS INC | 0 | reported | 07 Feb 2007 | tx 2+10,000−4,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 15,508 | 0.00 USD | |
| 14 May 2026 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 8,741 | 0.00 USD | |
| 11 May 2026 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 8,700 | 16.49 USD | |
| 11 May 2026 | SALE | COLLEGIUM PHARMACEUTICAL, INC | 8,700 | 37.18 USD | |
| 11 May 2026 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 8,700 | 0.00 USD | deriv |
| 28 May 2025 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 4,600 | 0.00 USD | deriv |
| 15 May 2025 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 9,791 | 0.00 USD | |
| 29 May 2024 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 69,000 | 0.00 USD | deriv |
| 14 May 2024 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 28,985 | 5.73 USD | |
| 16 May 2024 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 7,693 | 0.00 USD | |
| 14 May 2024 | SALE | COLLEGIUM PHARMACEUTICAL, INC | 28,985 | 32.30 USD | |
| 14 May 2024 | EXERCISE | COLLEGIUM PHARMACEUTICAL, INC | 28,985 | 0.00 USD | deriv |
| 12 Sept 2023 | PURCHASE | Karyopharm Therapeutics Inc. | 41,140 | 1.22 USD | first after silence |
| 24 May 2023 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 34,000 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 9,792 | 0.00 USD | |
| 19 May 2022 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 14,035 | 0.00 USD | |
| 19 May 2022 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 23,900 | 0.00 USD | deriv |
| 20 May 2021 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 9,941 | 0.00 USD | |
| 21 May 2021 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 23,900 | 0.00 USD | deriv |
| 06 May 2021 | PURCHASE | Karyopharm Therapeutics Inc. | 4,000 | 7.82 USD | |
| 21 May 2020 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 16,400 | 0.00 USD | deriv |
| 20 May 2020 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 4,047 | 0.00 USD | |
| 20 May 2020 | GRANT_AWARD | COLLEGIUM PHARMACEUTICAL, INC | 8,095 | 0.00 USD | deriv |
| 10 Jun 2019 | GRANT_AWARD | TETRAPHASE PHARMACEUTICALS INC | 16,500 | 0.00 USD | deriv |
| 06 Jun 2019 | GRANT_AWARD | Karyopharm Therapeutics Inc. | 25,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 12 Sept 2023.